» Articles » PMID: 30347439

Recruitment of Activated Neutrophils Correlates with Disease Severity in Adult Crohn's Disease

Overview
Date 2018 Oct 23
PMID 30347439
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Neutrophils are detected in inflamed colon in Crohn's disease (CD). However, whether the frequency and/or activation of circulating or gut tissue neutrophils correlate with endoscopic severity remains to be investigated. A cohort of 73 CD patients was prospectively enrolled according to endoscopic severity and treatment history. Individuals with active disease were stratified using the Montreal classification. Harvey-Bradshaw Index (HBI) and Simple Endoscopic Score for Crohn's Disease (SES-CD) were performed at the time of ileocolonoscopy. Frequency of neutrophils and their expression of CD66b and CD64 were assessed in paired blood and colonic biopsies using flow cytometry. The percentage of neutrophils increased in inflamed colon and correlated with SES-CD in the entire cohort of patients examined, as well as in the subgroup with inflammatory (B1) active disease. SES-CD further correlated with neutrophil CD66b expression in mucosa but not blood and, conversely, with neutrophil CD64 expression in blood but not mucosa. However, the evaluation of neutrophil activation in mucosa when compared to blood reflected disease activity more clearly. Finally, a neutrophil activation power index (CD66b in mucosa X CD64 in blood) that correlated with SES-CD discriminated between patients with mild and severe disease. In conclusion, the frequency and activation of colonic neutrophils correlated with SES-CD, highlighting that mucosal neutrophils are associated with disease severity in CD.

Citing Articles

Neutrophils: From Inflammatory Bowel Disease to Colitis-Associated Colorectal Cancer.

Chen T, Liu J, Hang R, Chen Q, Wang D J Inflamm Res. 2025; 18:925-947.

PMID: 39871958 PMC: 11770381. DOI: 10.2147/JIR.S497701.


Environmental and inflammatory factors influencing concurrent gut and lung inflammation.

Raftery A, Pattaroni C, Harris N, Tsantikos E, Hibbs M Inflamm Res. 2024; 73(12):2123-2139.

PMID: 39432107 PMC: 11632041. DOI: 10.1007/s00011-024-01953-x.


The Role of Propionate-Induced Rearrangement of Membrane Proteins in the Formation of the Virulent Phenotype of Crohn's Disease-Associated Adherent-Invasive .

Pobeguts O, Galyamina M, Mikhalchik E, Kovalchuk S, Smirnov I, Lee A Int J Mol Sci. 2024; 25(18).

PMID: 39337603 PMC: 11431891. DOI: 10.3390/ijms251810118.


Reciprocal regulation of protein arginine deiminase 2 and 4 expression in the colonic mucosa of ulcerative colitis.

Otsuka Y, Masuta Y, Minaga K, Okai N, Hara A, Takada R J Clin Biochem Nutr. 2024; 75(1):46-53.

PMID: 39070530 PMC: 11273265. DOI: 10.3164/jcbn.23-77.


Absolute monocyte counts could predict disease activity and secondary loss of response of patients with Crohn's disease treated with anti-TNF-α drug.

Hu J, Huang Y, Jia R, Wang X, Wang Y PLoS One. 2024; 19(4):e0301797.

PMID: 38598519 PMC: 11006187. DOI: 10.1371/journal.pone.0301797.


References
1.
Ivetic A . A head-to-tail view of L-selectin and its impact on neutrophil behaviour. Cell Tissue Res. 2018; 371(3):437-453. PMC: 5820395. DOI: 10.1007/s00441-017-2774-x. View

2.
Kolaczkowska E, Kubes P . Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013; 13(3):159-75. DOI: 10.1038/nri3399. View

3.
Ordas I, Feagan B, Sandborn W . Early use of immunosuppressives or TNF antagonists for the treatment of Crohn's disease: time for a change. Gut. 2011; 60(12):1754-63. DOI: 10.1136/gutjnl-2011-300934. View

4.
Khanna R, Nelson S, Feagan B, DHaens G, Sandborn W, Zou G . Endoscopic scoring indices for evaluation of disease activity in Crohn's disease. Cochrane Database Syst Rev. 2016; (8):CD010642. PMC: 7079710. DOI: 10.1002/14651858.CD010642.pub2. View

5.
Chapuy L, Bsat M, Mehta H, Rubio M, Wakahara K, Quang Van V . Basophils increase in Crohn disease and ulcerative colitis and favor mesenteric lymph node memory TH17/TH1 response. J Allergy Clin Immunol. 2014; 134(4):978-81.e1. DOI: 10.1016/j.jaci.2014.05.025. View